Skip to main content

Table 5 This shows the number of respondents that attended their primary care provider with symptoms from the NET

From: Delays and routes to diagnosis of neuroendocrine tumours

 

Primary Care

Secondary Care

Site of NET

Respondents

% seen by GP

Mean No. times seen by GP

Mean time GP investigated (months)

% seen in clinic

Mean No. times seen in clinic

Mean time clinic investigated (months)

Lung

51

73%

14

44

55%

3

4

Pancreas

52

73%

8

33

50%

4

21

Small Bowel

86

86%

10

40

62%

3

11

All/(mean)

257

(80%)

(11)

(37)

(58%)

(3)

(17)

  1. The number of visits related to the GP and also secondary care if referred via their GP. The final column encompasses all respondents that completed this part of the questionnaire and not separated by tumour site